Immunomic Therapeutics Announces Successful Completion of Series A Preferred Stock Financing Round by Sara Solt in Press Releases HERSHEY, PA & ROCKVILLE, MD (PRWEB) OCTOBER 28, 2014 Immunomic Therapeutics, Inc.(ITI), a vaccine pioneer in the biotechnology industry, today announced the successful completion of a $6.8 million Series A preferred ... Read More
